Mini-symposium: Footprints of Cancer Therapies – Cancelled
This event has been canceled due to the current outbreak of COVID-19.
This mini-symposium will bring together scientists interested in understanding the impact of cancer therapies on a molecular level in the cell, on the tumor and for the patient. It aims to provide an opportunity to learn about the changes cancer drugs confer on the genome, transcriptome and proteome and to learn on target-engagement and toxicity.
Päivi Östling, Karolinska Institutet/SciLifeLab
Ulrika Warpman, Karolinska Institutet/SciLifeLab
Anna Dimberg, Uppsala University/SciLifeLab
Registration is not available.